BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38377167)

  • 1. Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures.
    Liu Y; Kim ES; Guo H
    J Med Virol; 2024 Feb; 96(2):e29485. PubMed ID: 38377167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
    Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
    Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC.
    Li S; Xia H; Wang Z; Zhang X; Song T; Li J; Xu L; Zhang N; Fan S; Li Q; Zhang Q; Ye Y; Lv J; Yue X; Lv H; Yu J; Lu W
    Hepatology; 2023 Oct; 78(4):1079-1091. PubMed ID: 37114494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
    Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    Hetta HF; Zahran AM; Mansor SG; Abdel-Malek MO; Mekky MA; Abbas WA
    J Med Virol; 2019 Jul; 91(7):1319-1328. PubMed ID: 30761547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
    Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
    Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma.
    Bai Q; Li R; He X; Hong X; Yan Y; Zhao Z; Lin H; Tacke F; Engelmann C; Hu T
    Front Immunol; 2023; 14():1320414. PubMed ID: 38116005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
    Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
    Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
    Front Immunol; 2020; 11():1037. PubMed ID: 32547550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.
    Spaniel C; Honda M; Selitsky SR; Yamane D; Shimakami T; Kaneko S; Lanford RE; Lemon SM
    PLoS One; 2013; 8(10):e76867. PubMed ID: 24130799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis.
    Yu B; Zhi X; Li Q; Li T; Chen Z
    BMC Gastroenterol; 2023 Aug; 23(1):289. PubMed ID: 37612653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.